Australia Pharmaceuticals & Healthcare Report Q4 2013: New Research Report Available at Fast Market Research
Medicine price reductions and a slowing economy will continue to place downside pressures on pharmaceutical firms in Australia. Contributing to this, the government is looking to provide the population with affordable and sustainable pharmaceutical subsidies. However, the listing of new drugs, coupled with rising demand for pharmaceuticals due to the ageing population, will continue to provide both generic and innovative drugmakers with opportunities.
View full press release